FONAR Corporation (FONR)
USD 15.11
(-1.18%)
USD 15.11
(-1.18%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 41.67 Million USD | 12.61% |
| 2023 | 37 Million USD | -3.16% |
| 2022 | 38.21 Million USD | 10.15% |
| 2021 | 34.69 Million USD | -3.02% |
| 2020 | 35.77 Million USD | 11306.09% |
| 2019 | 313.64 Thousand USD | -8.92% |
| 2018 | 344.36 Thousand USD | -33.37% |
| 2017 | 516.85 Thousand USD | -88.53% |
| 2016 | 4.5 Million USD | -44.97% |
| 2015 | 8.18 Million USD | -27.99% |
| 2014 | 11.37 Million USD | -27.9% |
| 2013 | 15.77 Million USD | 499.52% |
| 2012 | 2.63 Million USD | -30.25% |
| 2011 | 3.77 Million USD | 63.56% |
| 2010 | 2.3 Million USD | 80.68% |
| 2009 | 1.27 Million USD | 12.99% |
| 2008 | 1.12 Million USD | 13.3% |
| 2007 | 997.12 Thousand USD | -29.07% |
| 2006 | 1.4 Million USD | 1.02% |
| 2005 | 1.39 Million USD | -79.24% |
| 2004 | 6.7 Million USD | 247.36% |
| 2003 | 1.92 Million USD | -81.81% |
| 2002 | 10.6 Million USD | -50.06% |
| 2001 | 21.24 Million USD | 1.31% |
| 2000 | 20.96 Million USD | -15.45% |
| 1999 | 24.8 Million USD | 55.0% |
| 1998 | 16 Million USD | 247.83% |
| 1997 | 4.6 Million USD | 15.0% |
| 1996 | 4 Million USD | 5.26% |
| 1995 | 3.8 Million USD | -36.67% |
| 1994 | 6 Million USD | -38.78% |
| 1993 | 9.8 Million USD | -19.01% |
| 1992 | 12.1 Million USD | -20.39% |
| 1991 | 15.2 Million USD | -17.84% |
| 1990 | 18.5 Million USD | -19.91% |
| 1989 | 23.1 Million USD | 153.85% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 40.9 Million USD | 14.18% |
| 2024 Q2 | 35.82 Million USD | -2.47% |
| 2024 Q1 | 36.73 Million USD | -0.75% |
| 2024 Q4 | 41.67 Million USD | 1.89% |
| 2023 Q4 | 37 Million USD | -1.72% |
| 2023 FY | 37 Million USD | -3.16% |
| 2023 Q1 | 38.2 Million USD | -0.02% |
| 2023 Q2 | 38.21 Million USD | 0.02% |
| 2023 Q3 | 37.65 Million USD | -1.46% |
| 2022 Q4 | 38.21 Million USD | -1.26% |
| 2022 Q1 | 33.38 Million USD | -3.76% |
| 2022 Q2 | 38.64 Million USD | 15.74% |
| 2022 Q3 | 38.7 Million USD | 0.15% |
| 2022 FY | 38.21 Million USD | 10.15% |
| 2021 Q4 | 34.69 Million USD | 1.94% |
| 2021 Q3 | 34.03 Million USD | -0.4% |
| 2021 Q2 | 34.17 Million USD | -2.49% |
| 2021 Q1 | 35.04 Million USD | -2.04% |
| 2021 FY | 34.69 Million USD | -3.02% |
| 2020 Q2 | 32.15 Million USD | -2.31% |
| 2020 Q3 | 31.38 Million USD | -2.42% |
| 2020 Q4 | 35.77 Million USD | 14.0% |
| 2020 Q1 | 32.91 Million USD | 10395.09% |
| 2020 FY | 35.77 Million USD | 11306.09% |
| 2019 Q4 | 313.64 Thousand USD | -2.6% |
| 2019 FY | 313.64 Thousand USD | -8.92% |
| 2019 Q1 | 337 Thousand USD | -2.14% |
| 2019 Q2 | 329 Thousand USD | -2.37% |
| 2019 Q3 | 322 Thousand USD | -2.13% |
| 2018 Q1 | 467 Thousand USD | -9.65% |
| 2018 Q4 | 344.36 Thousand USD | -6.17% |
| 2018 Q3 | 367 Thousand USD | -12.2% |
| 2018 Q2 | 418 Thousand USD | -10.49% |
| 2018 FY | 344.36 Thousand USD | -33.37% |
| 2017 Q1 | 3.09 Million USD | -31.28% |
| 2017 Q2 | 2.08 Million USD | -32.68% |
| 2017 FY | 516.85 Thousand USD | -88.53% |
| 2017 Q4 | 516.85 Thousand USD | -51.92% |
| 2017 Q3 | 1.07 Million USD | -48.44% |
| 2016 FY | 4.5 Million USD | -44.97% |
| 2016 Q1 | 7.56 Million USD | -7.61% |
| 2016 Q4 | 4.5 Million USD | -28.67% |
| 2016 Q2 | 6.94 Million USD | -8.25% |
| 2016 Q3 | 6.31 Million USD | -8.99% |
| 2015 FY | 8.18 Million USD | -27.99% |
| 2015 Q2 | 9.82 Million USD | -5.95% |
| 2015 Q3 | 9.2 Million USD | -6.33% |
| 2015 Q1 | 10.45 Million USD | -8.1% |
| 2015 Q4 | 8.18 Million USD | -11.05% |
| 2014 FY | 11.37 Million USD | -27.9% |
| 2014 Q4 | 11.37 Million USD | -8.07% |
| 2014 Q2 | 13.57 Million USD | -8.28% |
| 2014 Q1 | 14.8 Million USD | -6.15% |
| 2014 Q3 | 12.37 Million USD | -8.89% |
| 2013 Q2 | 2.11 Million USD | -10.45% |
| 2013 Q3 | 15.92 Million USD | 652.05% |
| 2013 Q4 | 15.77 Million USD | -0.93% |
| 2013 FY | 15.77 Million USD | 499.52% |
| 2013 Q1 | 2.36 Million USD | -10.14% |
| 2012 Q1 | 3.44 Million USD | -8.65% |
| 2012 Q2 | 3.12 Million USD | -9.29% |
| 2012 Q3 | 2.67 Million USD | -14.36% |
| 2012 Q4 | 2.63 Million USD | -1.72% |
| 2012 FY | 2.63 Million USD | -30.25% |
| 2011 FY | 3.77 Million USD | 63.56% |
| 2011 Q4 | 3.77 Million USD | -8.67% |
| 2011 Q3 | 4.13 Million USD | -0.17% |
| 2011 Q2 | 4.13 Million USD | 73.9% |
| 2011 Q1 | 2.37 Million USD | 3.16% |
| 2010 Q4 | 2.3 Million USD | -5.87% |
| 2010 Q3 | 2.45 Million USD | 104.68% |
| 2010 Q2 | 1.19 Million USD | -36.23% |
| 2010 Q1 | 1.87 Million USD | 47.06% |
| 2010 FY | 2.3 Million USD | 80.68% |
| 2009 Q1 | 1.57 Million USD | 39.77% |
| 2009 Q4 | 1.27 Million USD | 29.98% |
| 2009 FY | 1.27 Million USD | 12.99% |
| 2009 Q2 | 1.01 Million USD | -35.47% |
| 2009 Q3 | 982 Thousand USD | -3.63% |
| 2008 Q2 | 1.1 Million USD | -4.75% |
| 2008 Q1 | 1.15 Million USD | 16.03% |
| 2008 Q3 | 1.27 Million USD | 16.06% |
| 2008 Q4 | 1.12 Million USD | -11.67% |
| 2008 FY | 1.12 Million USD | 13.3% |
| 2007 Q3 | 1.25 Million USD | -4.58% |
| 2007 Q2 | 1.31 Million USD | -3.67% |
| 2007 Q1 | 1.36 Million USD | -3.18% |
| 2007 Q4 | 997.12 Thousand USD | -20.29% |
| 2007 FY | 997.12 Thousand USD | -29.07% |
| 2006 Q3 | 1.37 Million USD | -19.91% |
| 2006 Q4 | 1.4 Million USD | 2.46% |
| 2006 FY | 1.4 Million USD | 1.02% |
| 2006 Q1 | 1.43 Million USD | 2.91% |
| 2006 Q2 | 1.71 Million USD | 19.62% |
| 2005 Q3 | 848 Thousand USD | -86.87% |
| 2005 FY | 1.39 Million USD | -79.24% |
| 2005 Q4 | 1.39 Million USD | 64.09% |
| 2005 Q2 | 6.46 Million USD | -1.87% |
| 2005 Q1 | 6.58 Million USD | -1.78% |
| 2004 Q4 | 6.7 Million USD | -2.22% |
| 2004 FY | 6.7 Million USD | 247.36% |
| 2004 Q1 | 1.77 Million USD | -8.22% |
| 2004 Q2 | 1.42 Million USD | -19.59% |
| 2004 Q3 | 6.85 Million USD | 381.39% |
| 2003 FY | 1.92 Million USD | -81.81% |
| 2003 Q4 | 1.92 Million USD | -76.69% |
| 2003 Q1 | 9.69 Million USD | -8.62% |
| 2003 Q2 | 8.97 Million USD | -7.43% |
| 2003 Q3 | 8.27 Million USD | -7.77% |
| 2002 Q1 | 19.23 Million USD | -9.46% |
| 2002 Q2 | 16.97 Million USD | -11.74% |
| 2002 Q4 | 10.6 Million USD | -13.8% |
| 2002 Q3 | 12.3 Million USD | -27.5% |
| 2002 FY | 10.6 Million USD | -50.06% |
| 2001 Q3 | 17.36 Million USD | -9.92% |
| 2001 Q4 | 21.24 Million USD | 22.35% |
| 2001 FY | 21.24 Million USD | 1.31% |
| 2001 Q2 | 19.27 Million USD | -3.48% |
| 2001 Q1 | 19.97 Million USD | -4.76% |
| 2000 FY | 20.96 Million USD | -15.45% |
| 2000 Q4 | 20.96 Million USD | -1.98% |
| 2000 Q3 | 21.39 Million USD | -3.2% |
| 2000 Q2 | 22.1 Million USD | -5.56% |
| 2000 Q1 | 23.4 Million USD | -5.65% |
| 1999 Q3 | 25.1 Million USD | 2.45% |
| 1999 Q1 | 24.8 Million USD | 55.0% |
| 1999 FY | 24.8 Million USD | 55.0% |
| 1999 Q4 | 24.8 Million USD | -1.2% |
| 1999 Q2 | 24.5 Million USD | -1.21% |
| 1998 Q4 | 16 Million USD | 37.93% |
| 1998 FY | 16 Million USD | 247.83% |
| 1998 Q1 | 4.6 Million USD | 0.0% |
| 1998 Q2 | 4.3 Million USD | -6.52% |
| 1998 Q3 | 11.6 Million USD | 169.77% |
| 1997 Q2 | 3.4 Million USD | -10.53% |
| 1997 Q4 | 4.6 Million USD | 43.75% |
| 1997 Q1 | 3.8 Million USD | -5.0% |
| 1997 Q3 | 3.2 Million USD | -5.88% |
| 1997 FY | 4.6 Million USD | 15.0% |
| 1996 Q1 | 3.7 Million USD | -2.63% |
| 1996 FY | 4 Million USD | 5.26% |
| 1996 Q4 | 4 Million USD | 5.26% |
| 1996 Q3 | 3.8 Million USD | -5.0% |
| 1996 Q2 | 4 Million USD | 8.11% |
| 1995 Q2 | 4.8 Million USD | -9.43% |
| 1995 Q1 | 5.3 Million USD | -11.67% |
| 1995 Q3 | 4.5 Million USD | -6.25% |
| 1995 Q4 | 3.8 Million USD | -15.56% |
| 1995 FY | 3.8 Million USD | -36.67% |
| 1994 Q4 | 6 Million USD | -17.81% |
| 1994 FY | 6 Million USD | -38.78% |
| 1994 Q3 | 7.3 Million USD | -7.59% |
| 1994 Q1 | 9.1 Million USD | -7.14% |
| 1994 Q2 | 7.9 Million USD | -13.19% |
| 1993 Q1 | 11.4 Million USD | -5.79% |
| 1993 Q2 | 10.6 Million USD | -7.02% |
| 1993 Q3 | 10.2 Million USD | -3.77% |
| 1993 Q4 | 9.8 Million USD | -3.92% |
| 1993 FY | 9.8 Million USD | -19.01% |
| 1992 Q3 | 12.5 Million USD | 68.92% |
| 1992 FY | 12.1 Million USD | -20.39% |
| 1992 Q1 | 14.3 Million USD | -5.92% |
| 1992 Q2 | 7.4 Million USD | -48.25% |
| 1992 Q4 | 12.1 Million USD | -3.2% |
| 1991 Q1 | 10.1 Million USD | -45.41% |
| 1991 Q4 | 15.2 Million USD | 52.0% |
| 1991 Q2 | 9.2 Million USD | -8.91% |
| 1991 FY | 15.2 Million USD | -17.84% |
| 1991 Q3 | 10 Million USD | 8.7% |
| 1990 Q4 | 18.5 Million USD | 28.47% |
| 1990 Q3 | 14.4 Million USD | -6.49% |
| 1990 FY | 18.5 Million USD | -19.91% |
| 1990 Q2 | 15.4 Million USD | 0.0% |
| 1989 FY | 23.1 Million USD | 153.85% |
| 1989 Q4 | 23.1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 92.306% |
| Nemaura Medical Inc. | 20.03 Million USD | -108.066% |
| NeuroPace, Inc. | 72.39 Million USD | 42.433% |
| LENSAR, Inc. | 2.3 Million USD | -1704.932% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -467.327% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -2512.907% |
| Apyx Medical Corporation | 38.5 Million USD | -8.246% |
| Cutera, Inc. | 431.91 Million USD | 90.351% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -166.589% |
| BioSig Technologies, Inc. | 452 Thousand USD | -9120.325% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -6.262% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 97.522% |
| Axonics, Inc. | 27.61 Million USD | -50.907% |
| IRIDEX Corporation | 2.74 Million USD | -1417.694% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 47.382% |
| TELA Bio, Inc. | 42.78 Million USD | 2.581% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -11194.273% |
| RxSight, Inc. | 3.01 Million USD | -1283.661% |
| Align Technology, Inc. | 96.96 Million USD | 57.021% |
| INVO Bioscience, Inc. | 8.68 Million USD | -379.94% |
| electroCore, Inc. | 626 Thousand USD | -6557.487% |
| Telesis Bio, Inc. | 34.38 Million USD | -21.221% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -305.755% |
| Quipt Home Medical Corp. | 98.94 Million USD | 57.879% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -43.527% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1674.952% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -173.195% |
| Dynatronics Corporation | 6.68 Million USD | -523.149% |
| Modular Medical, Inc. | 1.19 Million USD | -3402.174% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -15806.82% |
| Talis Biomedical Corporation | 19.66 Million USD | -111.897% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -2953.088% |
| InMode Ltd. | 9.01 Million USD | -362.192% |
| Envoy Medical, Inc. | 404 Thousand USD | -10215.809% |
| Bruker Corporation | 1.37 Billion USD | 96.979% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -73015.56% |
| DexCom, Inc. | 2.59 Billion USD | 98.393% |
| Nexalin Technology, Inc. | 4463.00 USD | -933708.402% |
| PAVmed Inc | 48.72 Million USD | 14.467% |
| Viveve Medical, Inc. | 5.34 Million USD | -679.134% |
| Cerus Corporation | 95.99 Million USD | 56.587% |
| Movano Inc. | 252 Thousand USD | -16438.043% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -25.628% |
| Nexalin Technology, Inc. | 4463.00 USD | -933708.402% |
| IceCure Medical Ltd | 599 Thousand USD | -6857.574% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 89.974% |
| enVVeno Medical Corporation | 1.4 Million USD | -2872.601% |
| 908 Devices Inc. | 5.94 Million USD | -601.024% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -198.945% |
| Orthofix Medical Inc. | 134.19 Million USD | 68.945% |
| Surmodics, Inc. | 29.4 Million USD | -41.731% |
| Nuwellis, Inc. | 981 Thousand USD | -4148.305% |
| Outset Medical, Inc. | 136.18 Million USD | 69.398% |
| Venus Concept Inc. | 79.69 Million USD | 47.707% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 67.898% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 40.72% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -396.378% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -4332.113% |
| Inogen, Inc. | 21.92 Million USD | -90.101% |
| IRadimed Corporation | 2.04 Million USD | -1939.892% |
| MaxCyte, Inc. | 18.74 Million USD | -122.354% |
| Pulmonx Corporation | 41.42 Million USD | -0.608% |
| PAVmed Inc. | 48.72 Million USD | 14.467% |
| iCAD, Inc. | 461 Thousand USD | -8940.319% |
| OrthoPediatrics Corp. | 23.76 Million USD | -75.403% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -1987.446% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -8370.86% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -22500.797% |
| SI-BONE, Inc. | 38.99 Million USD | -6.883% |
| Semler Scientific, Inc. | 70 Thousand USD | -59436.956% |
| Beyond Air, Inc. | 17.83 Million USD | -133.648% |
| AxoGen, Inc. | 69.29 Million USD | 39.855% |
| Biotricity, Inc. | 23.87 Million USD | -74.531% |
| Cytosorbents Corporation | 18.31 Million USD | -127.573% |
| ZimVie Inc. | 521.92 Million USD | 92.015% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 17.269% |
| Inari Medical, Inc. | 32.04 Million USD | -30.046% |
| UFP Technologies, Inc. | 46.03 Million USD | 9.473% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -1987.446% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -1257.051% |
| Sight Sciences, Inc. | 35.41 Million USD | -17.682% |
| Insulet Corporation | 1.44 Billion USD | 97.123% |
| Profound Medical Corp. | 7.9 Million USD | -427.518% |
| Bioventus Inc. | 409.47 Million USD | 89.822% |
| InspireMD, Inc. | 1.59 Million USD | -2512.907% |
| BrainsWay Ltd. | 471 Thousand USD | -8748.38% |
| BIOLASE, Inc. | 17.91 Million USD | -132.696% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -3921.455% |
| Tenon Medical, Inc. | 1.17 Million USD | -3452.93% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -4059.268% |
| CVRx, Inc. | 30.61 Million USD | -36.138% |
| AdaptHealth Corp. | 2.29 Billion USD | 98.184% |
| Sintx Technologies, Inc. | 4.24 Million USD | -881.764% |
| Acutus Medical, Inc. | 38.47 Million USD | -8.308% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -1989.016% |
| NanoVibronix, Inc. | 5000.00 USD | -833417.38% |
| Quanterix Corporation | 41.46 Million USD | -0.511% |
| LivaNova PLC | 640.4 Million USD | 93.492% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -1293.578% |
| Varex Imaging Corporation | 469.5 Million USD | 91.123% |
| Vivani Medical, Inc. | 20.69 Million USD | -101.372% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1674.952% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -5222.589% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 95.538% |
| TransMedics Group, Inc. | 515.94 Million USD | 91.922% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -2090.009% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -17201.794% |
| Spectral AI, Inc. | 1.28 Million USD | -3133.194% |
| Hyperfine, Inc. | 185 Thousand USD | -22427.497% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 78.319% |
| Biomerica, Inc. | 785 Thousand USD | -5209.028% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -9171.957% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -11160.553% |
| Silk Road Medical, Inc | 84.63 Million USD | 50.757% |